HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study

BACKGROUND: Some observational studies have found increased HIV risk associated with self-reported use of injectable depot medroxyprogesterone acetate (DMPA). Testing blood samples for MPA, the progestin in DMPA, permits validation of self-reported data and exploration of whether potential HIV risk...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS
Main Authors: Heffron, Renee, Stalter, Randy, Pyra, Maria, Nanda, Kavita, Erikson, David W., Hladik, Florian, Blue, Steven W., Davis, Nicole L., Mugo, Nelly, Kourtis, Athena P., Lingappa, Jairam R., Baeten, Jared M.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6399047/
https://ncbi.nlm.nih.gov/pubmed/30585845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002123
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares